» Articles » PMID: 21471321

Characterization of the Effect of Heat on Agent Strains of the Transmissible Spongiform Encephalopathies

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2011 Apr 8
PMID 21471321
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The causal agents of the transmissible spongiform encephalopathy (TSE) diseases, sometimes called prion diseases, are characterized by high resistance to inactivation with heat. Results from thermal inactivation experiments on nine TSE strains, seven passaged in two PrP genotypes, showed differences in sensitivity to heat inactivation ranging over 17 °C. In addition, the rate of inactivation with increasing temperature varied between TSE models. In some cases passage in an alternative PrP genotype had little effect on the resulting inactivation properties, but for others the infectious agent was inactivated at lower temperatures. No strain with higher thermostability properties was selected. The effect of mixing two TSE strains, to see whether their properties were affected through interaction with each other, was also examined. The results showed that both strains behaved as expected from the behaviour of the unmixed controls, and that the strain responsible for inducing TSE disease could be identified. There was no evidence of a direct effect on intrinsic strain properties. Overall, the results illustrate the diversity in properties of TSE strains. They require intrinsic molecular properties of TSE agents to accommodate high resistance to inactivation and a mechanism, independent of the host, to directly encode these differences. These findings are more readily reconciled with models of TSE agents with two separate components, one of which is independent of the host and comprises a TSE-specific nucleic acid, than with models based solely on conformational changes to a host protein.

Citing Articles

Environmental and host factors that contribute to prion strain evolution.

Bartz J Acta Neuropathol. 2021; 142(1):5-16.

PMID: 33899132 PMC: 8932343. DOI: 10.1007/s00401-021-02310-6.


Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.

Langeveld J, Balkema-Buschmann A, Becher D, Thomzig A, Nonno R, Andreoletti O Vet Res. 2021; 52(1):59.

PMID: 33863379 PMC: 8052740. DOI: 10.1186/s13567-021-00928-8.


Assessing the aggregated probability of entry of a novel prion disease agent into the United Kingdom.

Horigan V, Gale P, Adkin A, Konold T, Cassar C, Spiropoulos J Microb Risk Anal. 2020; 16:100134.

PMID: 32837979 PMC: 7428426. DOI: 10.1016/j.mran.2020.100134.


Structural effects of the highly protective V127 polymorphism on human prion protein.

Hosszu L, Conners R, Sangar D, Batchelor M, Sawyer E, Fisher S Commun Biol. 2020; 3(1):402.

PMID: 32728168 PMC: 7391680. DOI: 10.1038/s42003-020-01126-6.


Evaluation of the Application for new alternative biodiesel production process for rendered fat of Cat 1 (BDI-RepCat process, AT).

Ricci A, Allende A, Bolton D, Chemaly M, Davies R, Girones R EFSA J. 2020; 15(11):e05053.

PMID: 32625346 PMC: 7009799. DOI: 10.2903/j.efsa.2017.5053.